• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿细胞学检查在神经源性下尿路功能障碍患者膀胱肿瘤检测中的临床应用价值

Clinical usefulness of urine cytology in the detection of bladder tumors in patients with neurogenic lower urinary tract dysfunction.

作者信息

Pannek Jürgen, Rademacher Franziska, Wöllner Jens

机构信息

Neuro-Urology, Swiss Paraplegic Center, Nottwil, Switzerland.

出版信息

Res Rep Urol. 2017 Dec 1;9:219-223. doi: 10.2147/RRU.S148429. eCollection 2017.

DOI:10.2147/RRU.S148429
PMID:29238702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5716319/
Abstract

INTRODUCTION

Screening for bladder cancer in patients with neurogenic lower urinary tract dysfunction is a challenge. Cystoscopy alone is not sufficient to detect bladder tumors in this patient group. We investigated the usefulness of combined cystoscopy and urine cytology.

MATERIALS AND METHODS

By a systematic chart review, we identified all patients with neurogenic lower urinary tract dysfunction who underwent combined cystoscopy and urine cytology testing. In patients with suspicious findings either in cytology or cystoscopy, transurethral resection was performed.

RESULTS

Seventy-nine patients (age 54.8±14.3 years, 38 female, 41 male) were identified; 44 of these used indwelling catheters. Cystoscopy was suspicious in 25 patients and cytology was suspicious in 17 patients. Histologically, no tumor was found in 15 patients and bladder cancer was found in 6 patients. Sensitivity for both cytology and cystoscopy was 83.3%; specificity was 43.7% for cytology and 31.2% for cystoscopy. One bladder tumor was missed by cytology and three tumors were missed by cystoscopy. If a biopsy was taken only if both findings were suspicious, four patients would have been spared the procedure, and one tumor would not have been diagnosed.

CONCLUSION

A combination of cystoscopy and urine cytology can improve bladder tumor detection rates and lower the number of unnecessary biopsies.

摘要

引言

对神经源性下尿路功能障碍患者进行膀胱癌筛查是一项挑战。仅靠膀胱镜检查不足以在该患者群体中检测出膀胱肿瘤。我们研究了膀胱镜检查与尿液细胞学检查联合应用的有效性。

材料与方法

通过系统的病历回顾,我们确定了所有接受膀胱镜检查与尿液细胞学检查联合检测的神经源性下尿路功能障碍患者。对于细胞学检查或膀胱镜检查有可疑发现的患者,进行经尿道切除术。

结果

共确定了79例患者(年龄54.8±14.3岁,女性38例,男性41例);其中44例使用留置导尿管。膀胱镜检查有可疑发现的患者有25例,细胞学检查有可疑发现的患者有17例。组织学检查发现,15例患者未发现肿瘤,6例患者发现膀胱癌。细胞学检查和膀胱镜检查的敏感性均为83.3%;细胞学检查的特异性为43.7%,膀胱镜检查的特异性为31.2%。细胞学检查漏诊了1例膀胱肿瘤,膀胱镜检查漏诊了3例肿瘤。如果仅在两项检查结果均可疑时才进行活检,4例患者可避免该手术,1例肿瘤将无法被诊断。

结论

膀胱镜检查与尿液细胞学检查联合应用可提高膀胱肿瘤的检出率,并减少不必要的活检数量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b94e/5716319/c4f4c0bc87d1/rru-9-219Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b94e/5716319/c4f4c0bc87d1/rru-9-219Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b94e/5716319/c4f4c0bc87d1/rru-9-219Fig1.jpg

相似文献

1
Clinical usefulness of urine cytology in the detection of bladder tumors in patients with neurogenic lower urinary tract dysfunction.尿细胞学检查在神经源性下尿路功能障碍患者膀胱肿瘤检测中的临床应用价值
Res Rep Urol. 2017 Dec 1;9:219-223. doi: 10.2147/RRU.S148429. eCollection 2017.
2
Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.核基质蛋白、纤连蛋白、膀胱癌抗原及晨尿细胞学检查在膀胱肿瘤检测中的比较评估
J Urol. 2002 Aug;168(2):465-9.
3
Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study.免疫细胞检测提高了尿液细胞学检查的诊断准确性:一项法国多中心研究的结果。
J Urol. 2003 Mar;169(3):921-4. doi: 10.1097/01.ju.0000048983.83079.4c.
4
Usefulness of urine cytology as a routine work-up in the detection of recurrence in patients with prior non-muscle-invasive bladder cancer: practicality and cost-effectiveness.尿细胞学检查作为既往非肌层浸润性膀胱癌患者复发检测常规检查的实用性和成本效益
Korean J Urol. 2014 Oct;55(10):650-5. doi: 10.4111/kju.2014.55.10.650. Epub 2014 Oct 10.
5
Do We Need Surveillance Urethro-Cystoscopy in Patients with Neurogenic Lower Urinary Tract Dysfunction?神经源性下尿路功能障碍患者是否需要监测性尿道膀胱镜检查?
PLoS One. 2015 Oct 29;10(10):e0140970. doi: 10.1371/journal.pone.0140970. eCollection 2015.
6
Reliability of urinary cytology and cystoscopy for the screening and diagnosis of bladder cancer in patients with neurogenic bladder: A systematic review.尿细胞学和膀胱镜检查用于神经源性膀胱患者膀胱癌筛查和诊断的可靠性:系统评价。
Neurourol Urodyn. 2018 Mar;37(3):916-925. doi: 10.1002/nau.23395. Epub 2017 Sep 19.
7
Assessing treatment response after induction Bacillus Calmette-Guerin for carcinoma in situ of the urinary bladder: can post-induction random bladder biopsies be avoided?评估卡介苗诱导治疗后膀胱原位癌的治疗反应:能否避免诱导治疗后的随机膀胱活检?
Cytopathology. 2014 Apr;25(2):108-11. doi: 10.1111/cyt.12064. Epub 2013 Apr 2.
8
Follow-up in non-muscle-invasive bladder cancer-International Bladder Cancer Network recommendations.非肌层浸润性膀胱癌的随访——国际膀胱癌网络建议
Urol Oncol. 2016 Oct;34(10):460-8. doi: 10.1016/j.urolonc.2016.05.028. Epub 2016 Jun 29.
9
Bladder cancer detection in patients with neurogenic bladder: are cystoscopy and cytology effective, and are biomarkers pertinent as future diagnostic tools? A scoping review.神经原性膀胱患者膀胱癌的检测:膀胱镜检查和细胞学检查是否有效,生物标志物是否作为未来的诊断工具相关? 范围综述。
World J Urol. 2022 Aug;40(8):1897-1913. doi: 10.1007/s00345-022-03943-2. Epub 2022 Feb 4.
10
Diagnostic value of voided urine and bladder barbotage cytology in detecting transitional cell carcinoma of the urinary tract.排尿尿液及膀胱灌洗细胞学检查在检测尿路移行细胞癌中的诊断价值。
Urol Int. 1999;62(1):26-30. doi: 10.1159/000030350.

引用本文的文献

1
Squamous cell carcinoma of the urinary bladder in patients with chronic spinal cord injury: A case series.脊髓损伤患者的膀胱鳞状细胞癌:病例系列。
Spinal Cord Ser Cases. 2024 Sep 14;10(1):67. doi: 10.1038/s41394-024-00680-z.
2
Urine Biomarkers in the Management of Adult Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review.成人神经源性下尿路功能障碍管理中的尿液生物标志物:一项系统评价。
Diagnostics (Basel). 2023 Jan 27;13(3):468. doi: 10.3390/diagnostics13030468.
3
Bladder cancer detection in patients with neurogenic bladder: are cystoscopy and cytology effective, and are biomarkers pertinent as future diagnostic tools? A scoping review.

本文引用的文献

1
Bladder cancer in individuals with spinal cord injuries: a meta-analysis.脊髓损伤患者的膀胱癌:一项荟萃分析。
Spinal Cord. 2017 Apr;55(4):341-345. doi: 10.1038/sc.2016.151. Epub 2016 Nov 8.
2
Do We Need Surveillance Urethro-Cystoscopy in Patients with Neurogenic Lower Urinary Tract Dysfunction?神经源性下尿路功能障碍患者是否需要监测性尿道膀胱镜检查?
PLoS One. 2015 Oct 29;10(10):e0140970. doi: 10.1371/journal.pone.0140970. eCollection 2015.
3
Screening for bladder cancer in individuals with spinal cord injury.脊髓损伤患者的膀胱癌筛查。
神经原性膀胱患者膀胱癌的检测:膀胱镜检查和细胞学检查是否有效,生物标志物是否作为未来的诊断工具相关? 范围综述。
World J Urol. 2022 Aug;40(8):1897-1913. doi: 10.1007/s00345-022-03943-2. Epub 2022 Feb 4.
4
Urine Cytology as Seen in Uyo, Nigeria: How Relevant Is It to Medical Practice?尼日利亚乌约地区所见的尿液细胞学检查:它对医疗实践有多大相关性?
Niger J Surg. 2020 Jul-Dec;26(2):95-98. doi: 10.4103/njs.NJS_48_19. Epub 2020 Jul 27.
5
Recommendations for urological follow-up of patients with neurogenic bladder secondary to spinal cord injury.脊髓损伤继发神经源性膀胱患者的泌尿外科随访建议。
Int Urol Nephrol. 2018 Jun;50(6):1005-1016. doi: 10.1007/s11255-018-1852-7. Epub 2018 Mar 22.
J Urol. 2015 Jun;193(6):1880-1. doi: 10.1016/j.juro.2015.03.069. Epub 2015 Mar 17.
4
Global cancer statistics, 2012.全球癌症统计数据,2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.
5
Bladder cancer mortality after spinal cord injury over 4 decades.40 余年来脊髓损伤后膀胱癌死亡率变化。
J Urol. 2015 Jun;193(6):1923-8. doi: 10.1016/j.juro.2015.01.070. Epub 2015 Jan 20.
6
Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer.尿细胞学及其他膀胱癌尿液生物标志物的敏感性和特异性的前瞻性分析。
Urol Oncol. 2015 Feb;33(2):66.e25-31. doi: 10.1016/j.urolonc.2014.06.008. Epub 2014 Jul 15.
7
Autonomic dysreflexia severity during urodynamics and cystoscopy in individuals with spinal cord injury.脊髓损伤患者尿动力学和膀胱镜检查期间的自主反射障碍严重程度。
Spinal Cord. 2013 Nov;51(11):863-7. doi: 10.1038/sc.2013.113. Epub 2013 Sep 24.
8
Bladder cancer in individuals with spinal cord injuries.脊髓损伤个体中的膀胱癌。
Spinal Cord. 2013 Jul;51(7):516-21. doi: 10.1038/sc.2013.33. Epub 2013 Apr 23.
9
Delay in diagnosis of cancer as a patient safety issue - a root cause analysis based on a representative case report.将癌症诊断延误作为一个患者安全问题——基于一份代表性病例报告的根本原因分析
Patient Saf Surg. 2011 Jul 29;5:19. doi: 10.1186/1754-9493-5-19.
10
A review on the current state of urine cytology emphasizing the role of fluorescence in situ hybridization as an adjunct to diagnosis.一篇关于尿细胞学现状的综述,重点介绍荧光原位杂交在诊断中的辅助作用。
Cancer Cytopathol. 2010 Aug 25;118(4):175-83. doi: 10.1002/cncy.20080.